Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 1, 1985
Allopurinol mouthwashes and 5-fluorouracil induced oral toxicityP I Clark, M L SlevinClinical Pharmacokinetics|April 1, 1987
The clinical pharmacology of etoposide and teniposideP I Clark, M L SlevinCancer Chemotherapy and Pharmacology|January 1, 1995
Stability of the i.v. and oral formulations of etoposide in solutionS P Joel, P I Clark, M L SlevinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Predicting etoposide toxicity: relationship to organ function and protein bindingS P Joel, R Shah, P I Clark, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacological attempts to improve the bioavailability of oral etoposideS P Joel, P I Clark, L Heap, et al.British Journal of Clinical Pharmacology|September 1, 1984
The influence of cimetidine on the pharmacokinetics of 5-fluorouracilV J Harvey, M L Slevin, M R Dilloway, et al.British Journal of Cancer|March 1, 1988
Oral urea in the treatment of secondary tumours in the liverP I Clark, M L Slevin, J A Webb, et al.British Journal of Hospital Medicine|July 1, 1987
Talking about cancer: how much is too much?M L SlevinInternational Journal of Colorectal Disease|February 1, 1987
Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancerP I Clark, M L Slevin, R H Reznek, et al.Pageof 13